Company: NDRA
Filing Date: 2025-10-17
Form Type: PRE 14A
Source: 0001654954-25-011931
Chunk: 13

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-10-17
Form: PRE 14A
Chunk 13
---
 |                                                  |      - |     |                                                      |   - |   |
| 5% Stockholders:                                            |     |                                       |           |     |                                           |   |                                                  |        |     |                                                      |     |   |
| Juan R. Rivero (8)                                          |     |                                       |           |     |                                           |   |                                                  | 17.488 |     |                                                      | 100 | % |

* Less than one percent.

| (1) | Consists of 3 shares of common stock and 63 shares of common stock issuable upon the exercise of options that are presently exercisable within 60 days of October 16, 2025 |

| 12 |

| (2) | Consists of 20 shares of common stock and 72 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of October 16, 2025. |
| (3) | Consists of 4 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of October 16, 2025.                                |
| (4) | Consists of 1 share of common stock and 6 shares of common stock issuable upon the exercise of options.                                                                                              |
| (5) | Consists of 70,881 shares of common stock and 9 shares of common stock issuable upon the exercise of options.                                                                                        |
| (6) | Consists of 2 shares of common stock and 9 shares of common stock issuable upon the exercise of options.                                                                                             |
| (7) | Consists of 5 shares of common stock and 9 shares of common stock issuable upon the exercise of options that are presently exercisable or becoming exercisable within 60 days of October 16, 2025.   |
| (8) | Mr. Rivero’s address is 14521 Jockey Circle, N. Davie, FL 33330.                                                                                                                                     |

<div align='center'>PROPOSAL 1 ‒ELECTION OF DIRECTORS</div>

The Company’s Board of Directors currently consists of four members. Upon the recommendation of the Corporate Governance and Nominating Committee of our Board of Directors, the Board of Directors has nominated the four current directors for election at the 2025 Annual Meeting to hold office until the next annual meeting of stockholders (each to serve until his successor is duly elected and qualified